Novo Nordisk’s Weekly Insulin Arrives in India as Buyback Buoys Shares Through Pipeline Blip
Novo Nordisk has opened the door to one of the world's fastest-growing diabetes markets with the launch of Awiqli in ...
Novo Nordisk has opened the door to one of the world's fastest-growing diabetes markets with the launch of Awiqli in ...
Novo Nordisk closed the week at €43.32, adding 1.29% on Friday alone, as a wave of analyst upgrades and a ...
Medicare Part D prescriptions for Wegovy surged nearly 600 percent within six months of the FDA’s March 2024 cardiovascular risk ...
Novo Nordisk is extending its oral Wegovy franchise across multiple fronts simultaneously, with a UK launch, a fresh liver fibrosis ...
The stock has surged more than 16% over the past month, yet the enthusiasm on Wall Street remains conspicuously muted. ...
A pair of catalysts is converging on Novo Nordisk just as the Danish drugmaker scrambles to expand its manufacturing footprint. ...
Novo Nordisk’s stock has clawed back more than a third of its losses since the March 2026 trough, closing at ...
The Danish pharmaceutical heavyweight arrived at the American Diabetes Association congress in New Orleans armed with a double dose of ...
The Danish drugmaker entered the week with a promising oral medication and emerged facing a cybersecurity crisis and a clinical ...
The Danish drugmaker is buying back its own stock at a furious pace just as the shares slide toward a ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com